Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

3.

Predictors of invasive disease in breast cancer when core biopsy demonstrates DCIS only.

Dillon MF, McDermott EW, Quinn CM, O'Doherty A, O'Higgins N, Hill AD.

J Surg Oncol. 2006 Jun 1;93(7):559-63.

PMID:
16705731
4.

Predictors of invasion and axillary lymph node metastasis in patients with a core biopsy diagnosis of ductal carcinoma in situ: an analysis of 255 cases.

Han JS, Molberg KH, Sarode V.

Breast J. 2011 May-Jun;17(3):223-9. doi: 10.1111/j.1524-4741.2011.01069.x. Epub 2011 Mar 24.

PMID:
21545433
5.

Selective approach to radionuclide-guided sentinel lymph node biopsy in high-risk ductal carcinoma in situ of the breast.

Usmani S, Khan HA, Al Saleh N, abu Huda F, Marafi F, Amanguno HG, Al Nafisi N, Al Kandari F.

Nucl Med Commun. 2011 Nov;32(11):1084-7. doi: 10.1097/MNM.0b013e328349eafc.

PMID:
21862942
6.

Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.

Kotani H, Yoshimura A, Adachi Y, Ishiguro J, Hisada T, Ichikawa M, Gondou N, Hattori M, Kondou N, Sawaki M, Fujita T, Iwata H.

Breast Cancer. 2016 Mar;23(2):190-4. doi: 10.1007/s12282-014-0546-y. Epub 2014 Jul 3.

PMID:
24989112
7.

Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.

Yen TW, Hunt KK, Ross MI, Mirza NQ, Babiera GV, Meric-Bernstam F, Singletary SE, Symmans WF, Giordano SH, Feig BW, Ames FC, Kuerer HM.

J Am Coll Surg. 2005 Apr;200(4):516-26.

PMID:
15804465
8.

Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?

Doyle B, Al-Mudhaffer M, Kennedy MM, O'Doherty A, Flanagan F, McDermott EW, Kerin MJ, Hill AD, Quinn CM.

J Clin Pathol. 2009 Jun;62(6):534-8. doi: 10.1136/jcp.2008.061457. Epub 2009 Feb 3.

PMID:
19190009
9.

Sentinel node biopsy for nonpalpable breast tumors requires a preoperative diagnosis of invasive breast cancer.

Rahusen FD, Meijer S, Taets van Amerongen AH, Pijpers R, van Diest PJ.

Breast J. 2003 Sep-Oct;9(5):380-4.

PMID:
12968957
10.

Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy.

Park HS, Park S, Cho J, Park JM, Kim SI, Park BW.

J Surg Oncol. 2013 Mar;107(4):388-92. doi: 10.1002/jso.23273. Epub 2012 Sep 24.

PMID:
23007901
11.

Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ.

Osako T, Iwase T, Ushijima M, Horii R, Fukami Y, Kimura K, Matsuura M, Akiyama F.

Cancer Sci. 2014 May;105(5):576-82. doi: 10.1111/cas.12381. Epub 2014 Mar 26.

12.

Independent predictors of breast malignancy in screen-detected microcalcifications: biopsy results in 2545 cases.

Farshid G, Sullivan T, Downey P, Gill PG, Pieterse S.

Br J Cancer. 2011 Nov 22;105(11):1669-75. doi: 10.1038/bjc.2011.466. Epub 2011 Nov 3.

13.

Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy.

Schulz S, Sinn P, Golatta M, Rauch G, Junkermann H, Schuetz F, Sohn C, Heil J.

Breast. 2013 Aug;22(4):537-42. doi: 10.1016/j.breast.2012.11.002. Epub 2012 Dec 11.

PMID:
23237921
14.

[Sentinel lymph node metastasis in patients with ductal breast carcinoma in situ].

Ruvalcaba-Limón E, de Jesús Garduño-Raya M, Bautista-Piña V, Trejo-Martínez C, Maffuz-Aziz A, Rodríguez-Cuevas S.

Cir Cir. 2014 Mar-Apr;82(2):129-41. Spanish.

PMID:
25312311
15.

Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in-situ and ductal carcinoma-in-situ with microinvasion?

Klauber-DeMore N, Tan LK, Liberman L, Kaptain S, Fey J, Borgen P, Heerdt A, Montgomery L, Paglia M, Petrek JA, Cody HS, Van Zee KJ.

Ann Surg Oncol. 2000 Oct;7(9):636-42.

PMID:
11034239
16.

Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases.

Goyal A, Douglas-Jones A, Monypenny I, Sweetland H, Stevens G, Mansel RE.

Breast Cancer Res Treat. 2006 Aug;98(3):311-4. Epub 2006 Mar 22.

PMID:
16552627
17.

Predicting invasion in mammographically detected microcalcification.

Bagnall MJ, Evans AJ, Wilson AR, Pinder SE, Denley H, Geraghty JG, Ellis IO.

Clin Radiol. 2001 Oct;56(10):828-32.

PMID:
11895299
18.

Stereotactic and sonographic large-core biopsy of nonpalpable breast lesions: results of the Radiologic Diagnostic Oncology Group V study.

Fajardo LL, Pisano ED, Caudry DJ, Gatsonis CA, Berg WA, Connolly J, Schnitt S, Page DL, McNeil BJ; Radiologist Investigators of the Radiologic Diagnostic Oncology Group V.

Acad Radiol. 2004 Mar;11(3):293-308.

PMID:
15035520
19.

Sentinel lymph node biopsy in patients with pure and high-risk ductal carcinoma in situ of the breast.

D'Eredità G, Giardina C, Napoli A, Ingravallo G, Troilo VL, Fischetti F, Berardi T.

Tumori. 2009 Nov-Dec;95(6):706-11.

20.

Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.

Mittendorf EA, Arciero CA, Gutchell V, Hooke J, Shriver CD.

Curr Surg. 2005 Mar-Apr;62(2):253-7.

PMID:
15796952

Supplemental Content

Support Center